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Objective: This study investigated a novel approach to induce chondrogenic differentiation of human
mesenchymal stem cells (hMSC). We hypothesized that a structured three-dimensional co-culture using
hMSC and chondrocytes would provide chondroinductive cues to hMSC without inducing hypertrophy.
Method: In an effort to promote optimal chondrogenic differentiation of hMSC, we created bilaminar cell
pellets (BCPs), which consist of a spherical population of hMSC encased within a layer of juvenile
chondrocytes (JC). In addition to histologic analyses, we examined proteoglycan content and expression
of chondrogenic and hypertrophic genes in BCPs, JC pellets, and hMSC pellets grown in the presence or
absence of transforming growth factor-b (TGFb) following 21 days of culture in either growth or chon-
drogenic media.
Results: In either growth or chondrogenic media, we observed that BCPs and JC pellets produced more
proteoglycan than hMSC pellets treated with TGFb. BCPs and JC pellets also exhibited higher expression
of the chondrogenic genes Sox9, aggrecan, and collagen 2A1, and lower expression of the hypertrophic
genes matrix metalloproteinase-13, Runx2, collagen 1A1, and collagen 10A1 than hMSC pellets. Histo-
logic analyses suggest that JC promote chondrogenic differentiation of cells in BCPs without hypertrophy.
Furthermore, when cultured in hypoxic and inﬂammatory conditions intended to mimic the injured joint
microenvironment, BCPs produced signiﬁcantly more proteoglycan than either JC pellets or hMSC pellets.
Conclusion: The BCP co-culture promotes a chondrogenic phenotype without hypertrophy and, relative to
pellet cultures of hMSCs or JCs alone, is more resistant to the adverse conditions anticipated at the site of
articular cartilage repair.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Damaged hyaline articular cartilage has a poor capacity for
self-repair. Injured articular cartilage is often replaced by
ﬁbrocartilaginous tissue which does not exhibit the same func-
tional and mechanical properties as hyaline cartilage1 and can lead
to osteoarthritis. A cell-based approach to cartilage repair has the
potential to overcome limitations of current osteoarthritis thera-
pies to restore the unique biological and mechanical properties of
this tissue. This approach requires an abundant source of cells that: T. Alliston, Department of
Parnassus, Medical Sciences
5-502-6523; Fax: 1-415-476-
on).
s Research Society International. Pcan proliferate, synthesize proteoglycan, and express collagen II
and aggrecan. Autologous chondrocytes are not optimal because
the harvesting procedure damages healthy cartilage. Donor chon-
drocytes can be obtained only in small numbers. Furthermore, both
chondrocyte populations often dedifferentiate during in vitro
expansion2. In contrast, autologous human mesenchymal stem
cells (hMSC) can be harvested and expanded readily. However,
hMSC require exogenous growth factors to induce chondrogenic
differentiation that can present unique challenges3,4.
Chondrogenic induction of hMSC is commonly performed using
three-dimensional pellet cultures in media containing trans-
forming growth factor-b (TGFb)5e9. TGFb is a potent chon-
droinductive agent, but in vitro it drives cells to adopt
a hypertrophic phenotype in which cells terminally differentiate,
undergo apoptosis, and produce matrix with inferior mechanical
properties. Though chondrocyte hypertrophy is essential inublished by Elsevier Ltd. All rights reserved.
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articular cartilage inwhich chondrocytes retain a stable phenotype.
As a result, a successful tissue engineering approach should
promote robust chondrogenic differentiation of hMSC and cartilage
matrix synthesis without hypertrophy, particularly when chal-
lenged by the inﬂammatory and hypoxic microenvironment of the
injured or osteoarthritic joint.
Co-culture of stem cells with a differentiated cell population has
been explored as an alternative to growth factors to direct stem cell
differentiation10. Rather than supplying a single growth factor, these
cellular interactions have the potential to generate a multitude of
biochemical and physical cues in a more physiologic dose, duration,
and sequence. Chondrocyte co-culturewith hMSC can overcome the
hMSC requirement for exogenous growth factors to enhance chon-
drogenic differentiation11e19. While the mechanisms remain
unclear, both chondrocyte and hMSC-derived soluble factors have
been implicated in the chondroinductive effects of co-culture.
However, conditioned media is insufﬁcient to confer this
advantage11,16, suggesting the need for bidirectional exchange of
soluble factors between the two cell types and/or a gradient of
soluble factors, neither of which are replicated by application of
conditioned media.
Invivoand invitrodata clearly indicate the importanceofphysical
and spatial cues in cell differentiation20,21. For example, physical
interactions among mesenchymal precursors and surrounding cell
types induce instructive signaling events that self-promote chon-
drogenesis in development21,22. Therefore, we hypothesized that
a structured bilaminar co-culture of hMSCwith chondrocyteswould
provide a combination of physical, spatial, and biochemical cues to
promote optimal chondrogenic differentiation and performance in
the adverse conditions anticipated in an injured joint. Previous
studies showed that structured co-culture of intervertebral disc cells
with hMSC outperformed mixed co-culture23. To determine if
structured co-culture is also an advantage for chondrogenesis, we
created a three-dimensional co-culture in which a spherical pop-
ulation of hMSC is surrounded by a layer of commercially prepared
juvenile chondrocytes (JC) derived fromcadaveric tissue fromyoung
donors20,23,24. The chondroinductive capacity of these bilaminar cell
pellets (BCPs) was evaluated in vitro in conditions that are optimal
for chondrogenesis as well as in conditions intended to mimic the
injured articular cartilage microenvironment.
Materials and methods
Cell culture
Commercially available bone marrow-derived hMSC from three
female donors (Lonza, MD) were expanded to the seventh passage
in growth media (DMEM low glucose, 1% penicillin/streptomycin
and 10% fetal bovine serum) at 37C with 5% CO2. Culture media
was changed three times a week. Juvenile human chondrocytes
were used as the instructive cell population (JC) and were derived
from cadaveric male donor tissue less than 13 years old (ISTO
Technologies, Inc.)24e26. JC were incorporated into pellets imme-
diately after thawing.
Pellet formation
Three types of pellets were formed, each consisting of
5105 cells: pellets of 100% single cell type (hMSC or JC) and
pellets of hMSC and JC organized into a BCP. To form 100% single
cell type pellets, 5105 cells were centrifuged in a 15 mL poly-
propylene tube at 300g for 5 min. To create BCPs, 3.75105 hMSC
were centrifuged in a 15 mL polypropylene tube at 300g for 5 min.
Subsequently, 1.25105 JC were added to the same tube andcentrifuged again at 300g for 5 min. Following centrifugation,
pellets were cultured for 3 days in polypropylene tubes with 2 mL
growthmediawith caps loosened to allow for gas exchange. During
this time, cells rearrange to create a layer of JC that surrounds the
hMSC pellet, resulting in a bilaminar spherical conﬁguration (20;
unpublished observations, M. Cooke and T. Alliston). Pellets were
then transferred to ultra-low attachment 24 well plates (Corning,
NY) and cultured for 21 days before harvesting. Growth media or
chondrogenic media (DMEM high glucose, 1% pen/strep, 1%
non-essential amino acids, 1% HEPES, 160 mM L-proline, 200 mM
ascorbic acid, 0.1 mM dexamethasone, 3109 M sodium selenite,
10 mg/mL transferrin, 10 mg/mL insulin) was changed three times
a week. Pellets were cultured in several conditions: normoxia;
hypoxia generated by an incubator maintaining 2% oxygen;
inﬂammatory conditions (10 ng/mL TNF-a and 10 ng/mL IL1b); or
hypoxia with inﬂammatory conditions.
Sulfated glycosaminoglycan (GAG) and DNA content
Pellets were digested in papain (20 U/mL in PBS) at 60C over-
night. Each digested lysate was independently assayed for GAG
content using the dimethylmethylene blue assay (DMMB) and for
DNA content using the Quant-iT PicoGreen kit (Invitrogen, CA). For
each spectrophotometric DMMB assay, GAG content was quantiﬁed
using a standard curve generated with bovine chondroitin sulfate
(Sigma, MO). Absorption was measured at 525 nm using a spec-
trophotometer. In growth media experiments, lysates were further
digestedwith DNAse Solution (50 mM Tris-HCL pH 7,10 mMMgCl2,
50 mg/mL BSA, 1 mL DNAse I per sample) (Roche, Germany) for
30 min at 37C prior to performing the DMMB assay, which
decreased the variability between technical replicates without
compromising the GAG measurements. The DMMB assay was
preformed in triplicate and the PicoGreen assay in duplicate for
each sample. For each condition using growth media, 10 pellets
were assayed (ten biological replicates of one pellet each, N¼ 10).
For each condition using chondrogenic media, 24 pellets were
assayed (eight biological replicates of three pellets each, N¼ 8).
Each experiment was powered to compensate for the high
variability in this assay.
Histological analysis
Pellets were ﬁxed in 4% paraformaldehyde at 4C overnight,
dehydrated with sequential ethanol washes, embedded in parafﬁn
and sectioned at 7 micron thickness. Immunohistochemistry (IHC)
was performed as described in the manufacturer’s instructions
(Mach 4 Universal HRP-Polymer Kit with DAB, Biocare Medical, CA)
with a 1:50 dilution of the primary mouse anti-aggrecan antibody
(SC-73693, Santa Cruz Biotechnology, CA). 3,30-Diaminobenzidine
(DAB) and a hematoxylin counterstainwere used to visualize bound
antibodies. For all histological analyses, ﬁgures show representative
images of N 3 biological replicates.
In situ hybridization was performed as described27. Brieﬂy,
sections were hybridized with 35S-labeled riboprobes that recog-
nize human aggrecan mRNA and human collagen-2a1 mRNA.
Sections were counterstained with Hoechst dye (Sigma, MO) to
visualize nuclei. Hybridization signals were detected using dark-
ﬁeld illumination and the nuclear stain was detected with
epiﬂuorescence.
Lipophilic tracers, DiI and DiO (Invitrogen, OR) were used to
label different cell populations. Brieﬂy, prior to creating pellets
some of the cells were incubated with 12.5 mg DiI or DiO per 1 mL
media for 3 h. Cells were washed and pelleted as described above.
BCP structure was observed in these pellets using a ﬂuorescence
microscope, Axiovert 40 CFL (Zeiss, NY).
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or JC originwithin the BCPs, we used FISH. Female hMSC andmale JC
were distinguished using dual-color human X and Y chromosome
DNA probes, CEP X Spectrum orange/CEP Y Spectrum green (Vysis,
Inc., IL). Sections were deparafﬁnized, rehydrated, and pre-treated
using the Histology FISH Accessory Kit (DAKO, Denmark) prior to
digestion for 40 min at 37C with 500 mg pepsin (Mallinckrodt, MO)
per 1 mL 0.9% sodium chloride. Sections were hybridized with FISH
probes overnight at 45C, washed with the provided buffers, coun-
terstained with DAPI II (Vysis, Inc), mounted, and visualized with
single-band excitation ﬁlters for rhodamine (excitation-525 nm,
emission-552 nm), FITC (excitation-490 nm, emission-525 nm), and
DAPI (excitation-350 nm, emission-470 nm) to visualize the X
chromosome, Y chromosome and nucleus respectively.
Analysis of gene expression
For pellets cultured in growth media, the total RNAwas isolated
and puriﬁed as described in product protocols for the QIAshredder
and RNeasy Mini Kits (Qiagen, Germany). RNA was reverse
transcribed using an iScript kit (Bio-Rad Laboratories, CA). Five
pellets of the same type and culture conditionwere pooled for each
biological replicate. A total of ﬁve biological replicates were
analyzed for each condition. Quantitative RT-PCR (Bio-Rad CFX96)
assessed gene expression using Taqman primer sets for each cDNA
(Applied Biosystems, CA; Table I). For pellets cultured in chondro-
genic media, the total RNAwas isolated and puriﬁed as described in
product protocols for the Cells to CT Kit (Invitrogen). Quantitative
RT-PCR assessed gene expression using SYBR Green primer sets for
each cDNA (Integrated DNA Technologies; Table II). For all
conditions, analysis was performed using primers and probes for
human Sox9, aggrecan, collagen 1A1, collagen 2A1, collagen
10A1,matrixmetalloproteinase-13 (MMP13), Runx2 and either L-19
or b-2-microglobulin (B2M). Fold changes were calculated accord-
ing to the comparative Ct method (ΔΔCtMethod) and normalized to
either L-19 or B2M. Statistics show the average and 95% conﬁdence
interval of ﬁve biological replicates for each condition (N¼ 5).
Analysis of protein expression
Pellets were lysed in RIPA lysis buffer at 4C28. Lysates were
sonicated 315 s on ice, clariﬁed bycentrifugation, and assessed by
SDS-PAGE and Western analysis using rabbit anti-Sox9 (SC-20095,
Santa Cruz Biotechnology, CA) and mouse anti-b-Actin (ab8226,
Abcam, MA) as previously described29. Western blot images are
representative of N 3 experiments. MMP13 protein expression
was evaluated using a commercially available enzyme activity assay
forHumanActiveMMP13 (R&D Systems,MN), in conditionedmedia
that was collected after 72 h from the indicated conditions and
concentrated with AmiconUltra-4 centrifugal ﬁlter devices (Mil-
lipore, Ireland). Statistics show the average and 95% conﬁdence
interval of three biological replicates for each condition (N¼ 3).
Statistical analysis
Data analysis was performed using standard analysis of variance
procedures (ANOVA, Minitab Software, PA) to calculate groupTable I
Taqman probe/Primer sets (Applied Biosystems)
Human collagen I Hs01028956_m1
Human collagen II Hs00156568_m1
Human aggrecan Hs00153936_m1
Human sox9 Hs00165814_m1
Human b2M Hs99999907_m1means and to test for the effects of pellet type (hMSC, hMSCþ TGFb,
JC, BCP; entered as categorical variables) and culture conditions
(normal media, hypoxia with inﬂammatory cytokines, hypoxia
alone, and inﬂammatory cytokines alone) on the measured
parameters of interest (L-19, B2M, aggrecan, collagen 2A1, Sox9,
Runx2, MMP13, collagen 1A1 and collagen 10A1, entered as
continuous predictors). When indicated, Tukey’s post-hoc tests
were used to judge pair-wise differences. Graphs represent the
average of biological replicates; error bars describe 95% conﬁdence
intervals, and P-values less than 0.001 are noted with an asterisk (*)
unless otherwise noted in the ﬁgure or ﬁgure legend. A group of
pellets of any given culture condition and cell type is derived from
the same cell sources and therefore individual pellets of a group do
not represent true biologic replicates. However, as the pellets were
grown separately for 21 days in culture we attribute differences
between the pellets to both technical variability and biologic
variability.
Results
Chondroinduction and hypertrophy of hMSCs
Consistent with previous studies5e7,30, hMSC pellet culture in
chondrogenic media containing TGFb induced robust expression of
aggrecan mRNA [Fig. 1(A)] and protein [Fig. 1(B)] and other chon-
drogenic genes (data not shown), particularly relative to hMSC
pellets grown in the same conditions without TGFb. However,
hMSC pellets cultured with TGFb also expressed high levels of the
hypertrophic chondrocyte marker genes, MMP13, Runx2, Collagen
I, and Collagen X [Fig. 1(C) and data not shown]. Consistent with
these results, TGFb treatment of hMSC also inducedMMP13 protein
expression [Fig. 1(D)].
BCP co-culture promotes proteoglycan production
We hypothesized that structured BCP co-culture is sufﬁcient to
induce chondrogenic differentiation without hypertrophy. The BCP
is a structured pellet co-culture comprised of a spherical population
of hMSC surrounded by a layer of JC [Fig. 2(A, B)]. To test this
hypothesis, we ﬁrst assessed proteoglycan content produced by the
pellets cultured in growth media that contains no added chon-
droinductive growth factors [Fig. 2(C)]. When BCPs were cultured
for 21 days in growth media (without chondroinductive growth
factors such as TGFb), the BCPs had signiﬁcantly greater presence of
GAG per cell than the hMSC pellets (2.03 fold increase P¼ 0.0015,
Fig. 3). No signiﬁcant differences in GAG production were apparent
between the BCP and JC pellet group (P¼ 0.6033). These results
suggest that BCP co-culture enhances proteoglycan production by
one or both cell types. Furthermore, the BCP co-culture was able to
produce an equivalent amount of proteoglycan as the 100% JC
pellets despite the fact that BCPs only contain 25% JC.
As a ﬁrst step in determining which cells in the pellets were
responsible for the production of proteoglycan, we next assessed
aggrecanmRNAandprotein expression histologically [Fig. 3(A, B)]. In
situ hybridization and IHC revealed that after 21 days of culture with
growth media, the BCPs qualitatively demonstrated more aggrecan
mRNA and protein expression compared to hMSC pellets [Fig. 3(A,
B)]. Furthermore, the aggrecan mRNA and protein was detected
centrally in the BCP, not only in the JC shell. The JC pellets showed
qualitatively more aggrecan than either the BCPs or hMSC pellets.
Bilaminar structure was retained in BCPs
To determine if the BCP co-culture retained its bilaminar
structured form throughout the 21-day differentiation period, we
Table II
SYBR green primers
SYBR green primer Forward Reverse
Human sox9 5-GAC TTC CGC GAC GTG GAC-3 5-GTT GGG CGG CAG GTA CTG-3
Human aggrecan 5-TCG AGG ACA GCG AGG CC-3 5-TCG AGG GTG TAG CGT GTA GAG A-3
Human collagen I 5-GTG GAA ACC CGA GCC CTG CC-3 5-TCC CTT GGG TCC CTC GAC GC-3
Human collagen II 5-AGG GCC AGG ATG TCC GGC AA-3 5-ACG AGG TCC AGG GGC ACC TTT T-3
Human collagen X 5-CAA GGC ACC ATC TCC AGG AA-3 5-AAA GGG TAT TTG TGG CAG CAT ATT-3
Human MMP13 5-TCT GAA CTG GGT CTT CCA AAA-3 5-GCA TCT ACT TTA TCA CCA ATT CCT-3
Human L-19 5-GGG ATT TGC ATT CAG AGA TCA G-3 5-GGA AGG GCA TCT CGT AAG-3
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within the BCP co-culture by FISH. Even after 21 days of culture, the
male JCs remained at the periphery of the BCP surrounding the
female hMSC [Fig. 3(C, D)]. Adjacent section FISH and aggrecan IHC
conﬁrmed that cells in the aggrecan-rich center of the BCP are
derived from a female donor, suggesting that hMSC in BCPs can
undergo chondrogenic differentiation.
BCPs induce chondrogenic differentiation without hypertrophy
We further quantiﬁed the chondrogenic performance of BCPs
relative to hMSC alone, which require TGFb for chondrogenic
differentiation. After 21 days of culture in growth media, the BCP
co-culture had greater expression of the chondrogenic genes Sox9
(3.81 fold, P< 0.0001), Col II (948 fold, P< 0.0001) and Aggrecan
(353 fold, P< 0.0001) than hMSC pellets cultured with TGFb
[Fig. 4(A)]. Not only did BCPs express more mRNA for anabolic
chondrocyte genes relative to hMSC pellets cultured with TGFb, but
they also expressed less mRNA for hypertrophic marker genes,
Runx2 (59.5% decrease P< 0.0001), Collagen X (99.6% decrease
P< 0.0001) and MMP13 (89.5% decrease P< 0.0001) [Fig. 4(C)].
These results are consistent with protein analyses, which showFig. 1. hMSC pellets cultured with TGFb express aggrecan, but also the hypertrophic gen
TGFb (5 ng/mL) express more aggrecan and MMP13 mRNA than comparable pellets grown
analyses: aggrecan IHC reveals greater staining in hMSC pellets cultured with TGFb compar
pellets cultured with TGFb than those cultured without TGFb, N¼ 3 (D). Error bars represeincreased endogenous Sox9 protein expression and reduced
secreted MMP13 protein in BCPs compared to hMSC pellets
cultured with TGFb [Fig. 4(B, D)].
Similar data were observed when the pellets were cultured in
chondrogenic media
Chondrogenic media supplements growth media with addi-
tional factors that encourage chondrogenic differentiation.
Accordingly, the studies were repeatedwith chondrogenicmedia to
compare the BCP model to a chondrocyte pellet culture in optimal
chondrogenic conditions. Unlike growth media, in which BCP and
JC pellets produce equivalent levels of proteoglycan, in chondro-
genic media, the JC pellets produced the greatest amount of
proteoglycan (18% more than BCPs P¼ 0.0038, 123% more than
hMSC P< 0.0001). This was conﬁrmed with aggrecan IHC staining
[Fig. 5(A, B)]. JC pellets showed maximal expression of the chon-
drogenic genes Sox9 (P< 0.0001), collagen 2A1 (P< 0.0001), and
aggrecan (P< 0.0001) [Fig. 5(C)]. After 21 days of culture in chon-
drogenic media, compared to hMSC pellets treated with TGFb, the
BCPs produced more proteoglycan (P< 0.0001) and had equivalent
expression of the chondrogenic gene collagen 2A1. In addition,e MMP13 (*, P< 0.001). hMSC pellets cultured in chondrogenic media for 21 days with
in the absence of TGFb, N¼ 5 (A, C). The gene expression data is conﬁrmed by protein
ed to those without TGFb, N 3 (B), and more MMP13 was detected in media of hMSC
nt 95% conﬁdence intervals.
Fig. 2. BCPs produce signiﬁcantly more GAG than hMSC pellets (þ, P¼ 0.0015 compared to hMSC; *, P¼ 0.0121 compared to hMSC). BCPs constructed with cell populations
labeled with DiI (red) or DiO (green), N 3 (A), show bilaminar structure as portrayed in a schematic (B). BCPs are intended to facilitate inductive interactions (arrow) between an
outer layer of male JC (XY, orange), and a core of female hMSC (XX, green). Following 21 days of culture in growth media, BCPs containing 75% hMSC and 25% JC produce as much
proteoglycan as pellets containing 100% JC as determined by DMMB analysis N¼ 10 (C). Error bars represent 95% conﬁdence intervals.
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phic genesMMP13, collagen 10A1 and collagen 1A1 compared to all
other pellet types (P< 0.0001) [Fig. 5(C)]. These results are
consistent with those in growth media, demonstrating that BCP
co-culture promotes chondrogenic gene expression without
hypertrophy.BCPs continue to produce proteoglycan in hypoxic and
inﬂammatory conditions
The injured articular cartilage microenvironment is hypoxic and
inﬂammatory. As expected, the proteoglycan synthesis of the JC
pellets was impaired in the presence of inﬂammatory cytokines. In
contrast, BCPs cultured in hypoxic, inﬂammatory, or combinedFig. 3. BCP co-culture is sufﬁcient to induce chondrogenic differentiation of hMSC.
In situ hybridization (A) and IHC (B) reveal that JC and BCP pellets express qualitatively
more aggrecan mRNA and protein than hMSC pellets. FISH detection of male JC (C) and
female hMSC (D), respectively, in boxed regions of (B). N 3 for all.conditions produced more proteoglycan than either hMSC and JC
pellets [all P< 0.02, speciﬁc P values listed in Fig. 6(A)]. Elevated
proteoglycan levels in BCPs occur even without signiﬁcant differ-
ences in cell number [Fig. 6(B)], suggesting that BCP co-culture
protects proteoglycan synthesis rather than cell proliferation or
viability.
Discussion
Our results demonstrate that a structured three-dimensional
co-culture, in which a spherical population of hMSC is sur-
rounded by a layer of JC, promotes a chondrogenic phenotype
without the induction of chondrocyte hypertrophy. The amount of
proteoglycan produced by BCPs was nearly equivalent to JC pellets
even though the BCPs contain only 25% JC cells. Furthermore, the
BCPs produce more proteoglycan than hMSC pellets or hMSC
pellets treated with TGFb. Taken together, these data indicate that
the structured co-culture of JC and hMSC in the BCP are inducing
chondrogenic differentiation. Most notably, in the setting of
inﬂammatory cytokines and/or hypoxia, BCPs outperform JC as well
as hMSC pellets in the production of proteoglycan. Therefore, the
unique combination of physical, spatial, and biochemical cues
provided by BCP co-culture overcomes several obstacles that
currently limit the utility of hMSC for articular cartilage repair.
Unlike TGFb-induced chondroinduction of hMSC, chondrogenic
differentiation in BCPs occurred with reduced hypertrophy. The
observation that BCP co-culture directs a more stable chondrogenic
differentiation than does TGFb is consistent with those of Aung
et al., who found that the co-culture of hydrogel-encapsulated
hMSC with chondrocytes enhanced differentiation without hyper-
trophy. Chondrocyte conditioned media was unable to replicate
this effect or that of BCP co-culture (data not shown16). Therefore,
chondroinduction requires an exchange of soluble factors between
the two cell populations, and/or a spatial gradient of these factors.
Although mass spectrometry studies by Aung et al. identiﬁed many
soluble factors present only in co-cultured media, which of the
co-culture-speciﬁc cues provided by BCP co-culture are responsible
for this stable chondrogenic differentiation remains unclear.
Nonetheless, several studies suggest factors that may be involved.
Speciﬁcally, TGFb is known to play an important role in the
Fig. 4. Unlike TGFb, BCP co-culture induces chondrogenic differentiation of hMSC without hypertrophy (*, P< 0.001; þ, P¼ 0.0021). Following 21 days of culture in growth
media, BCPs exhibit enhanced chondrogenic differentiation relative to TGFb-treated hMSC pellets, as shown by increased mRNA expression for anabolic chondrocyte marker genes
Sox9, Col 2A1, and aggrecan (A) and reduced mRNA expression of hypertrophic genes Runx2, Col 10A1 and MMP13 (C) as assessed by quantitative RT-PCR. Data are normalized to
b-2-macroglobulin expression and show averages of 5 biological replicates. The gene expression data is conﬁrmed by protein analyses: Western blotting conﬁrms the upregulation
of Sox9 in the BCPs compared to the TGFb-treated hMSCs, N 3 (B), and an enzyme activity assay conﬁrms the upregulation of MMP13 in the TGFb-treated hMSCs compared to the
BCPs N¼ 3 (D). Error bars represent 95% conﬁdence intervals.
Fig. 5. BCP co-culture performs similarly in chondrogenic media compared to culture in growth media (*, P< 0.001 compared to hMSC; þ, P< 0.001 compared to TGFb-treated
hMSC;A, P¼ 0.0038 compared to JC; x, P¼ 0.045 compared to hMSC). In chondrogenic media, BCP and JC pellets produce more proteoglycan compared to hMSC in the presence or
absence of TGFb as assessed by DMMB, N¼ 8 (A), a result that is consistent with Aggrecan IHC N 3 (B). JC pellets showed increased expression of chondrogenic genes relative to
BCPs and hMSCþ TGFb pellets. hMSCþ TGFb pellets had greater expression of hypertrophic genes than BCP pellets N¼ 5 (C). Error bars represent 95% conﬁdence intervals.
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Fig. 6. BCPs produce more GAG than hMSC or JC pellets when subjected to conditions that mimic the hypoxic, proinﬂammatory environment found in cartilage defects
(*, P< .001). A DMMB assay revealed a signiﬁcant advantage for BCP proteoglycan production relative to JC or hMSC pellets that were cultured with TNF-a (10 ng/mL) and IL1b
cytokines (10 ng/mL), and/or at 2% O2 for 21 days, N¼ 10 (A). Results were normalized to DNA content, N¼ 10 (B), which showed no statistical differences between the cell types
(hMSC, JC and BCP) within the conditions: TNF-a/IL1b, Hypoxia or Hypoxiaþ TNF-a/IL1b.
M.E. Cooke et al. / Osteoarthritis and Cartilage 19 (2011) 1210e12181216induction of chondrocyte lineage selection and in the regulation of
chondrogenic hypertrophy5. BCPs that were cultured with
SB431542, a speciﬁc pharmacologic inhibitor of the type I TGFb
receptor, showed a reduced expression of both pro-chondrogenic
(collagen 2A1 and aggrecan) and hypertrophic (MMP13 and
collagen 10A1) genes (data not shown). Likely, the combination of
factors produced by BCP co-culture modulate the hMSC response to
TGFb, such that the anabolic effects are enhanced, while
hypertrophy-inducing effects are suppressed. Other factors may
include agonists and antagonists of the ﬁbroblast growth factor
(FGF), hedgehog, bone morphogenetic protein (BMP) and Wnt
pathways22,31.
While several studies demonstrate the important role of soluble
factors in the chondroinductive effects of co-culture10,12e17,19,
physical and spatial cues may also participate18,23. In development,
the spatial juxtaposition of the perichondrium with the undiffer-
entiated mesenchymal cells provides a critical signaling feedback
loop that self-promotes chondrogenesis22. A computational model
predicts that a graded diffusion of soluble factors may impact
chondrogenic differentiation16. Our observations in BCPs may
provide experimental support for this model, suggesting that
cellular crosstalk between two cell populations across a boundary
or gradient may enhance the inductive effect. The report by Allon
et al. provides further support for this conclusion by demonstrating
that the structured BCP conﬁguration is superior to mixed
co-cultures of MSCs and chondrocyte-related nucleus pulposus
cells23. Since the BCP conﬁguration used herein is based on Allon
et al. we anticipate but have not yet veriﬁed similar advantages ofBCP culture over random mixtures of hMSC and chondrocytes.
Finally, physical cues ranging from extracellular matrix stiffness to
topographical cues have been shown to direct cell fate and may
contribute to the chondroinductive effects of BCPs32e35; important
points to consider as cells and engineered biomaterials are
combined to develop stem cell-based therapies.
Another key advantage of BCP co-culture is the ability of BCPs to
resist the adverse hypoxic and inﬂammatory conditions anticipated
in injured articular cartilage, which are recognized challenges to
the success of cartilage tissue engineering for the treatment of
osteoarthritis. This study found that BCPs maintain their chon-
drogenic potential under hypoxic and inﬂammatory conditions,
producing more proteoglycan than pellets composed of either cell
type alone. While hMSC are susceptible to hypoxia and JC are
susceptible to inﬂammatory conditions, the combined cell pop-
ulations in the BCP conferred resistance to these adverse environ-
ments, possibly due to the well-documented anti-inﬂammatory
capability of hMSC36,37 and the adaptation of chondrocytes to
hypoxic conditions. Though these results are provocative, a limita-
tion of our study is that we used two cytokines and hypoxia to
mimic the complex microenvironment of the injured joint. Addi-
tional studies are necessary to evaluate the performance of BCP
under in vivo conditions that more effectively model the healthy
and injured articular cartilage microenvironment.
Further study is also needed to conclusively demonstrate which
of the two cell populations in BCPs are responsible for the increased
proteoglycan production and chondrogenic gene expression.
Several prior studies have exploredwhether theMSC, chondrocytes,
M.E. Cooke et al. / Osteoarthritis and Cartilage 19 (2011) 1210e1218 1217or both are responsible for enhanced chondrogenesis in co-
cultures12e14,17,19. The possibility that BCP co-culture induces
chondrogenic differentiation of hMSC is supported by several lines
of evidence. First, the magnitude of proteoglycan production by
BCPs and JC pellets is comparable, even though BCPs contain 75%
hMSC. Second, histological analyses of BCPs show aggrecan mRNA
and proteoglycan deposition throughout the BCP, not only in the
outer shell composed of JC. Third, FISH analysis conﬁrmed that
aggrecan and safranin-O-positive regions of BCPs contained only
hMSC even after 21 days of culture. Fourth, similar analyses of BCPs
composed of 25% bovine nucleus pulposus cells and 75% human
MSC showed an induction of human (not bovine) collagen 2A1 and
aggrecan expression after 21 days of culture38. These results are
consistent with those in which co-culture of hMSC with chon-
drocytes or cartilagematrix, for example, in a transwell, can increase
expression of chondrocyte marker genes by hMSC12,13,39. Alterna-
tively, hMSC may promote increased levels of proteoglycan
production by the JC40. Human MSC are known to generate
instructive signals for other cell types, and several other studies
demonstrate that MSC increase chondrogenic capacity of chon-
drocytes in pellet co-cultures of these two cell types14,17,19. While
our data suggest that BCP co-culture promotes chondrogenic
differentiation of hMSC, it does not exclude the possibility that
hMSC enhance the chondrogenic activity of the human chon-
drocytes. Indeed, both mechanisms likely contribute.
In summary, our data indicate that the structured cellular
interactions within BCPs promote a robust chondrogenic pheno-
type, as demonstrated by proteoglycan production and chondro-
genic gene expression. Importantly, BCP co-culture addresses two
major limitations of cartilage tissue engineering: a limited chon-
drocyte supply and the generation of chondrocytes without
hypertrophy. hMSC are plentiful, therefore BCP formation may be
used to expand the limited supply of chondrocytes for cartilage
bioengineering. Furthermore, BCP co-culture does not require
exogenous growth factors nor does it exhibit a hypertrophic
phenotype. Although under chondrogenic conditions JC pellets
express genes indicative of a chondrogenic phenotype, chon-
drocytes are limited in supply and also have impaired production of
proteoglycan under inﬂammatory conditions that are seen in
osteoarthritic joints. By contrast, BCPs do not appear to be nega-
tively affected when exposed to inﬂammatory and hypoxic condi-
tions. Consequently, BCPs may provide signiﬁcant advantages as
a therapeutic approach for cartilage regeneration.
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